Merck

“After working 10 years on an individualized treatment against cancer using mRNA technology, the phase three was positive... it's the first time that there is an agent in melanoma that is better than Keytruda alone.”

“Only 60% of people are disease-free after five years... it means that there's 40% of people where you go through the treatment, you're fighting for cancer, and the treatment doesn't really work for you. And also... a lot of times come with very serious side effects”